How to kill epstein barr virus

how to kill epstein barr virus

A new way to control Epstein-Barr virus

May 28, EpsteinBarr virus (EBV) is a human herpesvirus found in 95% of the human population. Like other herpesviruses, EBV can be spread from person to person. However, the virus generally remains latentthat is, it lingers inside of cells without actively replicatingfor the lifetime of the host and rarely causes disease beyond the initial. May 29, EpsteinBarr virus (EBV) is a human herpesvirus found in 95% of the human population. Like other herpesviruses, EBV can be spread from person to person. However, the virus generally remains.

A team of researchers at University of Utah Health have shown the Epstein-Barr virus which causes mononucleosis and is linked to development of several cancers uses a novel strategy to ki,l. The researchers say the work is in the early stages but one day they hope to exploit this knowledge to develop a new kind of treatment for infection by the Vvirus virus. Like other herpesviruses, EBV can be spread from person to person. However, the virus generally remains latentthat is, it lingers inside of cells without actively replicatingfor the lifetime of the host and rarely causes what are behavioral questions in interviews beyond the initial infection.

In some cases, though, environmental triggers, including stress or coincident infections and immune suppression, create conditions in which the virus can thrive, occasionally sparking a rare type of lymphoma or other cancer.

Four years ago, the U of U Health research team found that spironolactone, a medicine routinely used to treat heart failure, has an unexpected antiviral activity against EBV. Several years ago, a group of French researchers found that spironolactone degrades a host protein called XPB, which plays an important role baer cellular transcription one of the first steps in gene expression.

Following up runescape how to level up fast this lead, How to kill epstein barr virus and his colleague Dinesh Verma conducted a series of experiments to epztein the potential link between the two proteins that the drug interacts with, XPB and SM.

The researchers first used a molecular biology technique to specifically lower the amount of XPB in host cells. The result was that the virus wpstein to reactivate and acted as if it no longer had functional SM. Finally, the researchers used a technique that involved chemically tagging uridine, one of the ot building blocks of the RNA alphabet, to study replication of the virus. Using this technique, they demonstrated that knocking bbarr XPB resulted in lower levels of messenger RNAs for 15 specific viral proteins whose production SM facilitated, while expression of other EBV genes was not affected.

According to Epsein, these 15 proteins perform functions that allow the virus to replicate in healthy people. In patients whose immune systems are compromised, these very same propertieskeeping the infected cells alive and helping them evade the immune systemcan lead to unchecked proliferation, a common characteristic of cancer.

The researchers are now trying to find new drugs that target XPB to prevent reactivation of EBV and other human herpesviruses in transplant patients, HIV patients, and other immunocompromised patients. Research News iii.

Help Us Eliminate Cancer

Drink Celery Juice Daily Celery is rich in trace minerals and polyphenolic anti-oxidants that support the adrenals and the immune system. Juicing celery can help restore adrenal balance giving you more energy and strengthen the immune system so it can suppress Epstein Barr and other viral infections. Mar 06, I've heard about a new ultraviolet machine called the UVLRx that's being used for Epstein Barr patients. It uses a fiber optic thread which is inserted directly into the vein and the treatment lasts for an hour, so all the blood is treated. Mar 27, This includes: getting enough rest drinking plenty of fluids taking over-the-counter pain relievers to ease fever or sore throat avoiding contact sports or heavy lifting.

A team of researchers at University of Utah Health have shown the Epstein-Barr viruswhich causes mononucleosis and is linked to development of several cancersuses a novel strategy to survive. The virus takes the reins of its host's cellular machinery to make copies of itself and to prioritize the production of its own proteins over those of the host cell.

The researchers hope to exploit this knowledge to develop a new kind of treatment for infection by the Epstein-Barr virus. Like other herpesviruses, EBV can be spread from person to person. However, the virus generally remains latentthat is, it lingers inside of cells without actively replicatingfor the lifetime of the host and rarely causes disease beyond the initial infection. In some cases, though, environmental triggers, including stress or coincident infections and immune suppression , create conditions in which the virus can thrive, occasionally sparking a rare type of lymphoma or other cancer.

Four years ago, the U of U Health research team found that spironolactone, a medicine routinely used to treat heart failure, has an unexpected antiviral activity against EBV. Now, they've figured out more about how it works and have published their findings in the Proceedings of the National Academy of Sciences.

Several years ago, a group of French researchers found that spironolactone degrades a host protein called XPB, which plays an important role in cellular transcriptionone of the first steps in gene expression. Following up on this lead, Swaminathan and his colleague Dinesh Verma conducted a series of experiments to explore the potential link between the two proteins that the drug interacts with, XPB and SM.

The researchers first used a molecular biology technique to specifically lower the amount of XPB in host cells. The result was that the virus failed to reactivate and acted as if it no longer had functional SM. Finally, the researchers used a technique that involved chemically tagging uridine, one of the four building blocks of the RNA alphabet, to study replication of the virus.

Using this technique, they demonstrated that knocking down XPB resulted in lower levels of messenger RNAs for 15 specific viral proteins whose production SM facilitated, while expression of other EBV genes was not affected.

According to Swaminathan, these 15 proteins perform functions that allow the virus to replicate in healthy people. In patients whose immune systems are compromised, these very same propertieskeeping the infected cells alive and helping them evade the immune systemcan lead to unchecked proliferation, a common characteristic of cancer.

The researchers are now trying to find new drugs that target XPB to prevent reactivation of EBV and other human herpesviruses in transplant patients, HIV patients, and other immunocompromised patients. Explore further. Your feedback will go directly to Science X editors. Thank you for taking your time to send in your valued opinion to Science X editors. You can be assured our editors closely monitor every feedback sent and will take appropriate actions.

Your opinions are important to us. We do not guarantee individual replies due to extremely high volume of correspondence. Learn more Your name Note Your email address is used only to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.

You can unsubscribe at any time and we'll never share your details to third parties. More information Privacy policy. This site uses cookies to assist with navigation, analyse your use of our services, and provide content from third parties.

By using our site, you acknowledge that you have read and understand our Privacy Policy and Terms of Use. May 29, This electron microscopic image of two Epstein Barr Virus virions viral particles shows round capsidsprotein-encased genetic materialloosely surrounded by the membrane envelope. Credit: DOI: More information: Dinesh Verma et al. DOI: Provided by University of Utah Health Sciences. This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission.

The content is provided for information purposes only. Possible new PET tracer for early detection of Alzheimer's 7 hours ago. Related Stories. Hidden in plain sight: Well-known drug could yield new treatment for herpes viruses Mar 14, Feb 14, May 11, How the immune system keeps the Epstein-Barr virus in check May 30, Aug 29, Recommended for you.

Scientists uncover a molecule that can help coronavirus escape antibodies 11 hours ago. Scientists cast new understanding of how skin repairs itself 18 hours ago. User comments. What do you think about this particular story? Your message to the editors. Your email only if you want to be contacted back. Send Feedback. E-mail the story A new way to control Epstein-Barr virus. Your friend's email. Your email. I would like to subscribe to Science X Newsletter.

Learn more. Your name. Note Your email address is used only to let the recipient know who sent the email. Your message. Your Privacy This site uses cookies to assist with navigation, analyse your use of our services, and provide content from third parties.

Ok More Information. E-mail newsletter. It appears that you are currently using Ad Blocking software. What are the consequences?

2 thoughts on “How to kill epstein barr virus”

Add a comment

Your email will not be published. Required fields are marked*